Response to Taiwan is on track of accelerating hepatitis C elimination by 2025

Affiliations

¹ Center for Disease Analysis, Lafayette, CO, USA.
² AbbVie Inc, North Chicago, IL, USA.
³ AbbVie Ltd., Australia.
⁴ Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.

Comment

Homie Razavi et al. Liver Int. 2020 Jun.

. 2020 Jun;40(6):1507.

doi: 10.1111/liv.14457. Epub 2020 Apr 24.

¹ Center for Disease Analysis, Lafayette, CO, USA.
² AbbVie Inc, North Chicago, IL, USA.
³ AbbVie Ltd., Australia.
⁴ Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.

No abstract available

Comment on

Global timing of hepatitis C virus elimination in high-income countries.
Razavi H, Sanchez Gonzalez Y, Yuen C, Cornberg M. Razavi H, et al. Liver Int. 2020 Mar;40(3):522-529. doi: 10.1111/liv.14324. Epub 2019 Dec 23. Liver Int. 2020. PMID: 31815353
Taiwan is on track of accelerating hepatitis C elimination by 2025.
Wu GH, Pwu RF, Chen SC, Chen DS. Wu GH, et al. Liver Int. 2020 Jun;40(6):1506-1507. doi: 10.1111/liv.14412. Epub 2020 Mar 8. Liver Int. 2020. PMID: 32086990 No abstract available.